Medical News

RSS

Sunlight Research's Stem Cell Industry Report analyzes U.S. Stem Cell patent landscape

Sunlight Research – The Source for Patent Analysis, today announced the release of its comprehensive Stem Cell Industry Report analyzing the U.S. Stem Cell patent landscape. Stem cells are particularly attractive for use as cellular therapies because they self-renew and have the capacity to produce many different specialized cell types.

16 Apr 2010

Self-monitoring of Coumadin levels reduces risk of blood clots by 50%: Study

A new review of existing research finds that many patients who take an anti-clotting drug or "blood-thinner" can benefit from monitoring the levels of the drug themselves instead of going to clinics for blood tests.

16 Apr 2010

IRS official: If an individual fails to show insurance coverage, refund could be withheld

"The Internal Revenue Service won't audit you to make sure you have purchased health insurance under provisions of the new health-care law—but it may withhold your tax refund if you can't demonstrate that you are insured, an IRS official said Thursday," The Wall Street Journal reports. "There are tools we can use. We obviously will be notifying folks [for whom there is no record of health insurance] that we have these questions," Steven T. Miller, IRS deputy commissioner for services and enforcement, said.

16 Apr 2010

Rexahn Pharmaceuticals to present RX-8243 anticancer compound data at 101st AACR Annual Meeting

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it will present pre-clinical data on its anticancer compound RX-8243 at the American Association for Cancer Research (AACR) 101st Annual Meeting, held in Washington, D.C., April 17-21, 2010, at the Walter E. Washington Convention Center.

16 Apr 2010

Results from Romark Laboratories' STEALTH C-3 clinical trial presented at EASL Annual Meeting

Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented as a late breaking communication at the International Liver Congress™ 2010, the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.

16 Apr 2010

FDA grants marketing clearance for Cambridge Heart's MTWA OEM module

Cambridge Heart, Inc., today announced that it has received clearance from the U.S. Food and Drug Administration to begin marketing its Microvolt T-Wave Alternans (MTWA) OEM module. The MTWA OEM module is designed to work with existing cardiac stress test platforms distributed by other manufacturers. This FDA 510(k) clearance allows Cambridge Heart to begin marketing the MTWA OEM module integrated with the Q-Stress line of stress systems manufactured by Cardiac Science Corporation, Inc..

16 Apr 2010

Long-term monitoring and education needed to protect lungs of young patients

St. Jude Children's Research Hospital investigators have identified childhood cancer survivors who are at increased risk for deteriorating lung health, in part due to the lifesaving bone marrow transplants they underwent years earlier.

16 Apr 2010

Private insurers seek to help states manage Medicaid expansion

The Wall Street Journal reports on plans by the health insurer UnitedHealth Group Inc. to issue a report Thursday on managed care strategies that "it says will help cash-strapped states solve budget problems and doctor shortages that hobble the government health-care programs for the poor."

16 Apr 2010

Age-related declines in peripheral nerve function may be related to metabolic factors: Study

New research investigating neurological decline in a population of "super healthy" elderly subjects found that the decline in neurological function of the peripheral nervous system attributed to aging may be related to metabolic factors, such as blood sugar levels, even if these factors are within the normal range.

16 Apr 2010

Marker Seven designs and develops new Website for CCHP

Marker Seven, an award-winning digital agency, has just completed the design and development of a brand new Website for The Center for Connected Health Policy. The site allows CCHP to reach a broad audience with its work to advance the integration of telehealth technologies into the state's healthcare system.

16 Apr 2010

Rudd announces funds for north coast NSW cancer centers

Prime Minister Kevin Rudd had announced a regional cancer center in the mid-north coast on Tuesday at Port Macquarie. He says plans are underway to invest almost $5 million for a second linear accelerator at the Port Base Hospital.

16 Apr 2010

Embryos with two mums to remove the risk of hereditary diseases: new research

New research published in the journal Nature, could pave the way to world’s first genetically modified human baby. The research involves making embryos with genes from one man and two women. There are hundreds or families around the world who are left childless or have serious ill babies because they carry genes for hereditary illnesses. This research may bring hope to such couples. According to scientists on the team, within the next three years these women will be able to avail such techniques. There has been skepticism regarding ethical issues attached to making of “designer babies”.

16 Apr 2010

Escherichia coli cases drop in 2009

As per a report from the Centers for Disease Control and Prevention (CDC) a 12 % drop in rates of Escherichia coli (E.coli) infection has been noted in 2009 as compared to statistics for 2008. This is being seen by federal health officials as a sign that the new food safety measures are effective. Most of the pathogens under study are from the bacteria family like E.coli 0157, salmonella, campylobacter, listeria and vibrio. It was found that food poisoning rates for the most common pathogens have changed little from statistics collected in 2004.

16 Apr 2010

To ban or not to ban trans fats

Now it is doctors too who have joined the move towards banning trans fats from food. Trans fats are hydrogenated solid fats that are found in deep fried foods, margarine, bakery products, fast foods etc. they are used because they are cheap and keep better. However it has long been known that these fats are bad for the heart leading to heart attacks, strokes and high blood cholesterol etc.

16 Apr 2010

Senate Foreign Relations Committee passes legislation to create USAID Office of Water

"The Senate Foreign Relations Committee approved legislation [by voice vote] Tuesday launching a government effort to provide 100 million people in the world's poorest countries with first-time access to safe drinking water and modern sanitation," CongressDaily reports.

16 Apr 2010

Idaho Technology receives USASMDC contract to develop flu tests for military personnel

Idaho Technology, Inc. has been awarded a contract by the U.S. Army Space and Missile Defense Command (USASMDC) to develop tests for multiple flu strains on the Joint Biological Agent Identification and Diagnostic System (JBAIDS).

16 Apr 2010

Worry over unmanned ambulances: Plans for extra manpower at Geelong call center for emergency calls

According to a recent statement of the paramedic’s union, Moe’s ambulances are often unmanned putting the lives of all the residents at risk.

16 Apr 2010

Investigations and attempts to fix the major QH staff pay bungle

After the recent mistake in payment of the Queensland Health staff much has been debated. In this huge error nearly 3000 people working for QH have been left un-paid or underpaid.

16 Apr 2010

Trans-urethral prostate hyperthermia treatment offers 100% response rate

According the Dr. Friedrich Douwes, Medical Director of St. George Hospital in Bad Aibling, Germany, president of the German Oncological Society and the author of several hundred scientific articles and books, trans-urethral prostate hyperthermia has a 100% initial response rate.

16 Apr 2010

UALR researcher receives federal grant to track estrogen-mimicking compounds in consumer products

Dr. Jerry Darsey, professor of chemistry in UALR's College of Science and Mathematics, has received $77,000 from a federal Food and Drug Administration grant to develop methods to track estrogen mimicking compounds in various products and assess how use of the products affect women.

16 Apr 2010

Medical News

Sunlight Research's Stem Cell Industry Report analyzes U.S. Stem Cell patent landscape

Self-monitoring of Coumadin levels reduces risk of blood clots by 50%: Study

IRS official: If an individual fails to show insurance coverage, refund could be withheld

Rexahn Pharmaceuticals to present RX-8243 anticancer compound data at 101st AACR Annual Meeting

Results from Romark Laboratories' STEALTH C-3 clinical trial presented at EASL Annual Meeting

FDA grants marketing clearance for Cambridge Heart's MTWA OEM module

Long-term monitoring and education needed to protect lungs of young patients

Private insurers seek to help states manage Medicaid expansion

Age-related declines in peripheral nerve function may be related to metabolic factors: Study

Marker Seven designs and develops new Website for CCHP

Rudd announces funds for north coast NSW cancer centers

Embryos with two mums to remove the risk of hereditary diseases: new research

Escherichia coli cases drop in 2009

To ban or not to ban trans fats

Senate Foreign Relations Committee passes legislation to create USAID Office of Water

Idaho Technology receives USASMDC contract to develop flu tests for military personnel

Worry over unmanned ambulances: Plans for extra manpower at Geelong call center for emergency calls

Investigations and attempts to fix the major QH staff pay bungle

Trans-urethral prostate hyperthermia treatment offers 100% response rate

UALR researcher receives federal grant to track estrogen-mimicking compounds in consumer products

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News